Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.
Willard MD, Lajiness ME, Wulur IH, Feng B, Swearingen ML, Uhlik MT, Kinzler KW, Velculescu VE, Sjöblom T, Markowitz SD, Powell SM, Vogelstein B, Barber TD.
Willard MD, et al. Among authors: lajiness me.
Mol Cancer Res. 2012 Jun;10(6):739-49. doi: 10.1158/1541-7786.MCR-11-0483. Epub 2012 Apr 19.
Mol Cancer Res. 2012.
PMID: 22516348
Free PMC article.